Arkolith/Insider Trading/ARMP/Form 4

Innoviva Strategic Opportunities LLC

Director, 10% OwnerArmata Pharmaceuticals, Inc. (ARMP) · full profile →Form 4 · filed Feb 11, 2022
Net Buying
Open-Market Buys
$18.1M
Open-Market Sells
$0
Net Open-Market Flow
$18.1M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2022Buy(P)3.6M$5.00$18.1M11.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2022Buy(P)1.8M$5.00$9.0M1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-003750) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML